Found 733 events where Vaccine is VARZOS and Serious

VAERS ID: 290451 (history)   Vaccinated: 2007-08-05 Age: 75.0   Onset: 2007-08-05, Days after vaccination: 0 Gender: Female   Submitted: 2007-09-12, Days after onset: 38 Location: Nevada   Entered: 2007-09-13, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? Yes Recovered? Yes ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: GLUCOTROL mg, lorazepam mg, oxybutynin mg Current Illness: Urinary incontinence; Diabetes; Sleeplessness; Penicillin allergy; Drug hypersensitivity Preexisting Conditions: Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0709USA00602
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     IM UN
Administered by: Other     Purchased by: Other Symptoms: Fatigue, Incorrect route of drug administration, Malaise, Pain, Pyrexia SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad) Write-up: Information has been received from a physician concerning a 75 white female with urinary incontinence, diabetes, sleeplessness and penicillin, codeine, Ambien allergies who on approximately 05-AUG-2007 (or 06-AUG-2007) was vaccinated IM with a single dose of Zostavax (Oka/Merck). Concomitant therapy included oxybutynin (02-AUG-2007 to 05-AUG-2007), Glucotrol XL (September 2006) and lorazepam (September 2006). On 06-AUG-2007, about 24 hours after vaccination the patient felt like she had achyness around the thorax and felt like she was going to get a shingles rash. It was reported that the patient felt achyness thoughout, had fever (on 07-AUG-2007), malaise and fatigue (on 06-AUG-2007) for 7 days and then felt ok. At the time of report the patient had recovered. The patient''s experience was considered to be disabling by the reporter. Additional information has been requested.
VAERS ID: 290452 (history)   Vaccinated: 2007-08-27 Age: 77.0   Onset: 2007-09-01, Days after vaccination: 5 Gender: Female   Submitted: 2007-09-12, Days after onset: 11 Location: Michigan   Entered: 2007-09-13, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? No Recovered? Yes ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: [therapy unspecified] Current Illness: Hypertension Preexisting Conditions: PMH: HTN, H. pylori, GERD, high cholesterol, arthritis Diagnostic Lab Data: blood culture - no infection, platelet count 70000 LABS: Blood c/s neg. Urine c/s gram positive cocci. Phosphorous 1.7(L). LFTs elevated. CXR WNL. Platelets 71. WBC 5.7. Rapid strep neg. IgG 499 (L). IgM 361 (H). Varicella IgG & IgM (+) CDC 'Split Type': WAES0709USA00813
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     UN UN
Administered by: Other     Purchased by: Other Symptoms: Blood culture, Blood culture negative, Blood immunoglobulin G decreased, Blood immunoglobulin M increased, Blood phosphorus, Chest X-ray normal, Culture urine positive, Dizziness, Fatigue, Hypotension, Liver function test abnormal, Nausea, Oral mucosal eruption, Pharyngeal erythema, Pharyngolaryngeal pain, Platelet count decreased, Pyrexia, Rash vesicular, Renal failure acute, Septic shock, Streptococcus identification test, Syncope, Thrombocytopenia, Urinary tract infection, Viral DNA test positive, Vomiting SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Agranulocytosis (broad), Haematopoietic thrombocytopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (narrow) Write-up: Information has been received from a physician concerning a 77 year old female with hypertension and no known allergies who on approximately 27-AUG-2007 was vaccinated with a single dose of Zostavax (Oka/Merck). Concomitant therapy included unspecified blood pressure medication. On an unspecified night (not the same night as the vaccination) after having dinner the patient developed nausea. The patient sought medical attention at the hospital and food poisoning was ruled out. Blood work revealed the patient had thrombocytopenia, platelet count 70,000 and blood culture revealed no infection. She was admitted to the hospital. The patient had no rash. The patient "is slightly getting better" since being admitted to the hospital. No further information was provided. There was no product quality complaint involved. The patient''s thrombocytopenia and nausea were considered serious for hospitalization. Additional information has been requested. 10/8/07 Patient demographics provided by CDC. 10/16/07 Reviewed hospital medical records which reveal patient experienced low blood pressure, nausea, vomiting, fever, fatigue, sore throat, dizziness, syncope. Exam revealed hypotension, throat erythema & vesicular lesions in mouth/throat. Admitted 9/5-9/8/2007. Tx w/IV antibiotics & antivirals FINAL DX: UTI, septic shock, acute renal failure, thrombocytopenia secondary to septic shock.
VAERS ID: 290869 (history)   Vaccinated: 2007-07-06 Age: 90.0   Onset: 2007-07-07, Days after vaccination: 1 Gender: Female   Submitted: 2007-09-05, Days after onset: 60 Location: New York   Entered: 2007-09-19, Days after submission: 14	Life Threatening? No Died? Yes    Date died: 2007-07-28    Days after onset: 21 Permanent Disability? No Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Synthroid, Metoprolol, Lisinopril, Digitek, Zoloft, Warfarin, B-12 supplement Current Illness: None Preexisting Conditions: Hypothyroid, Atrial Fib, CHF, high blood pressure PMH: depression, osteoporosis, mitral regurgitation, dysuria, hyponatremia, anemia, B12 deficiency. Diagnostic Lab Data: Complete Blood Work, Blood Cultures, on heart monitor, CT scan of Brain (3x), EEG - all normal LABS: EKG revealed a-fib & bradycardia. CDC 'Split Type':
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (NO BRAND NAME) UNKNOWN MANUFACTURER     UN UN
Administered by: Private     Purchased by: Other Symptoms: Anaemia, Asthenia, Atrial fibrillation, Blood culture negative, Blood test normal, Bradycardia, Cardio-respiratory arrest, Computerised tomogram normal, Confusional state, Contusion, Death, Dysphagia, Electrocardiogram abnormal, Electroencephalogram normal, Facial palsy, Fall, Full blood count normal, Gait disturbance, Hypertension, Hypothyroidism, Incontinence, Lethargy, Memory impairment, Mental status changes, Mitral valve incompetence, Somnolence, Speech disorder, Staring, Syncope SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Haematopoietic erythropenia (broad), Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (narrow), Arrhythmia related investigations, signs and symptoms (broad), Supraventricular tachyarrhythmias (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Dementia (broad), Parkinson-like events (broad), Acute central respiratory depression (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Hypertension (narrow), Cardiomyopathy (broad), Hypothyroidism (narrow), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad) Write-up: Shot (vaccine) given 7/6/07. 7/7/07 Somewhat not responding to conversation. 7/8/07 - Very sleepy, hard time answering questions, difficulty getting out of chair - as the next 20 days progressed, she experienced feeling of weakness, some facial droop, swallowing difficulties, unable to answer questions (stare, then a shrug [I don''t know]), confusion, incontinence, walk very slowly, occasional dragging of foot. Just before she died (approx 17 hours earlier), she described some things that she did at rehab. Her descriptions were rather odd - after she said them, she realized they sounded odd and stated she thought she must be going crazy - she knew something wasn''t right. She went from being able bodied, alert, communicative, capable person to unable to do simple personal tasks. An otherwise healthy person does not have a rapid change as this one without a reason. All tests run came back perfectly normal - 3 Cat scans showed nothing wrong. Blood work - that of a 50 year old. No evidence of stroke. Drs - both primary MD and Hospital staff said vaccine couldn''t have done it. Symptoms occurred w/in 24 hours of getting vaccine. 9/25/07 Received medical records & death certificate from pcp which reveals COD as cardio-respiratory arrest with atrial fibrillation, mitral regurgitation, HTN, hypothyroid, anemia as contributing factors. Medical records reveal patient in usual state of health & on Coumadin for a. fib when received zostavax on 7/6/07 but no lot # provided. Returned to pcp on 7/9/07 after a fall 7/8/07 & now w/trouble ambulating & speech & memory were slow. No hx of neuro problems & no current head injury, but w/bruising of right arm. Dx at that time: syncope. Admitted directly to hospital. Returned to pcp on 7/18 for hospital f/u. Receiving home health RN, PT/OT & was doing poorly w/dysphagia, lethargy/sleepiness & incontinence. Readmitted to hospital directly. 10/9/07 Reviewed hospital medical records which reveal patient experienced fall at AL facility, seen in pcp office & direct admitted to hospi
VAERS ID: 290938 (history)   Vaccinated: 2007-09-05 Age:    Onset: 2007-09-05, Days after vaccination: 0 Gender: Female   Submitted: 2007-09-19, Days after onset: 14 Location: Texas   Entered: 2007-09-20, Days after submission: 1	Life Threatening? Yes Died? No Permanent Disability? No Recovered? Yes ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Unknown Current Illness: Preexisting Conditions: None Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0709USA01999
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     SC UN
Administered by: Other     Purchased by: Other Symptoms: Cerebral haemorrhage SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic cerebrovascular conditions (narrow) Write-up: Information has been received from a physician concerning a female consumer with no pertinent history who on approximately 05-SEP-2007 was vaccinated SC with a 0.65 ml dose of Zostavax. On approximately 05-SEP-2007 the patient developed a cerebral hemorrhage and was hospitalized. The condition was considered to be immediately life-threatening per the physician. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
VAERS ID: 290939 (history)   Vaccinated: 0000-00-00 Age: 68.0   Onset: 2007-09-11 Gender: Female   Submitted: 2007-09-19, Days after onset: 8 Location: Washington   Entered: 2007-09-20, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? Yes Recovered? Yes ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Unknown Current Illness: Preexisting Conditions: Unknown Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0709USA02217
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     UN UN
Administered by: Other     Purchased by: Other Symptoms: Herpes zoster SMQs: Write-up: Information has been received from a physician concerning a 68-year-old female who in the "spring of 2007" was vaccinated with a dose of Zostavax (Oka/Merck) (lot# not available). On 11-SEP-2007 the patient was diagnosed with shingles. Unspecified medical attention was sought. The outcome is reported as not recovered. No product quality complaint was involved. The reporter considered shingles to be disabling or incapacitating. Additional information has been requested.
VAERS ID: 291029 (history)   Vaccinated: 2007-09-05 Age: 66.0   Onset: 2007-09-07, Days after vaccination: 2 Gender: Female   Submitted: 2007-09-20, Days after onset: 13 Location: Unknown   Entered: 2007-09-21, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? No Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: corticosteroids (unspecified); [therapy unspecified] Current Illness: Allergic reaction to antibiotics Preexisting Conditions: Diagnostic Lab Data: None CDC 'Split Type': WAES0709USA01062
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 0882U   SC UN
Administered by: Other     Purchased by: Other Symptoms: Injection site erythema, Injection site swelling, Pyrexia, Transient ischaemic attack SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Ischaemic cerebrovascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow) Write-up: Information has been received from a pharmacist and technician concerning a 66 year old female with allergic reaction to quinolones and no reported medical history who on 05-SEP-2007 was vaccinated with Zostavax (lot # 658085/0882U). Concomitant therapy included a steroid injection and other unspecified medications. On 07-SEP-2007 the patient experienced fever, swelling and redness at the injection site. The patient sought the medical attention of the pharmacist. On 14-SEP-2007 the patient contacted the pharmacy and reported that she was admitted to the hospital on 11-SEP-2007 for a "mini-stroke". She was released on 13-SEP-2007. The patient is recovering from her events. Additional information has been requested.
VAERS ID: 291030 (history)   Vaccinated: 0000-00-00 Age: 55.0   Onset: 0000-00-00 Gender: Male   Submitted: 2007-09-20 Location: New York   Entered: 2007-09-21, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? No Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Unknown Current Illness: Preexisting Conditions: Unknown Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0709USA01767
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     UN UN
Administered by: Other     Purchased by: Other Symptoms: Cellulitis, Inappropriate schedule of drug administration, Injection site erythema, Injection site swelling SMQs:, Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow) Write-up: Information has been received from a physician concerning a 55-year-old male who on an unspecified date was vaccinated with a dose of Zostavax. Subsequently, the patient experienced swelling and redness at and around the injection site. The patient was hospitalized because it was possibly thought to be cellulitis. No outcome reported. No product quality complaint was involved. Additional information has been requested.
VAERS ID: 291478 (history)   Vaccinated: 2007-08-28 Age: 91.0   Onset: 2007-09-01, Days after vaccination: 4 Gender: Female   Submitted: 2007-09-26, Days after onset: 25 Location: Minnesota   Entered: 2007-09-27, Days after submission: 1	Life Threatening? No Died? No Permanent Disability? No Recovered? Yes ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: None Current Illness: Drug hypersensitivity Preexisting Conditions: Diagnostic Lab Data: diagnostic laboratory - results not provided CDC 'Split Type': WAES0709USA03265
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 0882U   SC UN
Administered by: Other     Purchased by: Other Symptoms: Herpes zoster, Laboratory test, Malaise SMQs: Write-up: Information has been received from a consumer concerning her 91 year old mother with a morphine allergy and no pertinent medical history who on 28-AUG-2007 was vaccinated SC with a 0.65 ml dose of Zostavax (Oka/Merck) (Lot#658085/0882U). There was no concomitant medication. On 01-SEP-2007 the patient felt ill and was taken to the emergency room. The next morning 02-SEP-2007 she was admitted into the hospital. Later that day she was diagnosed with shingles. Unspecified "blood tests" were performed. No results were reported. She was discharged from the hospital on 03-SEP-2007. At the time of this report the patient had not recovered. There was no further information provided. There was no product quality complaint involved. This report is serious due to hospitalization. Additional information has been requested.
VAERS ID: 291479 (history)   Vaccinated: 2007-09-01 Age:    Onset: 2007-09-01, Days after vaccination: 0 Gender: Female   Submitted: 2007-09-26, Days after onset: 25 Location: New York   Entered: 2007-09-27, Days after submission: 1	Life Threatening? Yes Died? No Permanent Disability? Yes Recovered? Yes ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Unknown Current Illness: Preexisting Conditions: Unknown Diagnostic Lab Data: Unknown CDC 'Split Type': WAES0709USA03423
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC.     SC UN
Administered by: Other     Purchased by: Other Symptoms: Oedema peripheral, Respiratory distress, Swelling face SMQs:, Cardiac failure (broad), Anaphylactic reaction (narrow), Angioedema (narrow), Acute central respiratory depression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow) Write-up: Information has been received from a physician concerning a female who in September 2007, was vaccinated SC with a dose of Zostavax. Soon after vaccination the patient experienced respiratory distress. It was reported that the patient''s face and arm was swollen. The physician did send the patient to the emergency room. It was not known if the patient was admitted to the hospital. Unspecified medical attention was sought. A product quality complaint was not involved. The patient''s experiences were considered to be life-threatening and disabling by the reporter. Additional information has been requested.
VAERS ID: 291495 (history)   Vaccinated: 2007-09-13 Age: 79.0   Onset: 2007-09-27, Days after vaccination: 14 Gender: Female   Submitted: 2007-09-27, Days after onset: 0 Location: Florida   Entered: 2007-09-27	Life Threatening? No Died? No Permanent Disability? No Recovered? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: Current Illness: None Preexisting Conditions: PMH: diverticulosis, ascending thoracic aortic aneurysm, GERD, hypothyroidism, hyperlipidemia, HTN, osteopenia, lumbar stenosis, vasomotor rhinitis. Hospitalized 1/06 for influenza. Allergic PCN & codeine. Diagnostic Lab Data: LABS: EKG WNL. Cardiac enzymes (-). CXR WNL. CT of abdomen & pelvis revealed markedly distended urinary bladder. Renal scan WNL. Urine & blood c/s neg. Na 131 (L) CDC 'Split Type':
Vaccination Manufacturer Lot Dose Route Site VARZOS: ZOSTER (ZOSTAVAX) MERCK & CO. INC. 0885U 0 SC RA
Administered by: Private     Purchased by: Private Symptoms: Abdominal pain lower, Bladder catheter permanent, Bladder obstruction, Blood culture negative, Blood sodium decreased, Cardiac enzymes normal, Chest X-ray normal, Computerised tomogram abnormal, Culture urine negative, Electrocardiogram normal, Herpes zoster, Hyponatraemia, Insomnia, Pain, Post herpetic neuralgia, Rash, Ultrasound kidney normal, Urinary retention SMQs:, Anaphylactic reaction (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hyponatraemia/SIADH (narrow), Chronic kidney disease (broad), Hypersensitivity (narrow) Write-up: pt hospitalized 9/20/07-9/25/07 for RLQ pain, developed right T12 HZV rash on 9/27/07-tx''d with Acyclovir 1gm q 8 hr x 7d. Dx. Herpes zoster. 10/5/07 Reviewed hospital medical records which reveal patient experienced right sided abdominal pain & difficulty sleeping 9/19 while out of town. Saw pcp on 9/20 & admitted 9/20-9/25/2007. Urinary catheter inserted w/large residual. Tx w/oral antibiotics. Abdominal pain resolved. FINAL DX: acute abdominal pain of unknown etiology; bladder outlet obstruction; hyponatremia. 11/9/07 Received pcp medical records which included vax record. Confirms lot # as reported. Seen s/p hospitalization on 9/26 & had developed right T12 HXV rash evening before with pain. Tx w/antiviral & pain med. Returned to pcp 10/3 still having pain. Tx w/neurontin. Returned to pcp 10/11. Pain improved w/neurontin & pain med & was to start tapering both off as tolerated. Returned to pcp 10/31 w/increased pain & med increased. FINAL DX: Zoster infection w/post herpetic pain. Per 60 day follow up: R thoracic post herpetic neuritis. 1/12/2010 Right lumbar postherpetic neurolgia on gabapentin.